Dr Biggs stated in a letter to Dr Sheila Waiter that Commercial Human Factor 8 should be made available to doctors who treat patients with haemophilia as an interim measure until enough can be made by the NHS.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Rosemary Biggs
Dr Sheila Waiter